SCHEMBL23966829

SCHEMBL23966829

Cc1cccc2c1C(=O)O/C2=C/CC(=O)OC(C)(C)C

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.36
MAPT P10636 4/20 0.36
KMT2A Q03164 4/20 0.36
NPC1 O15118 3/20 0.36
HPGD P15428 3/20 0.36
RAB9A P51151 3/20 0.36
MEN1 O00255 2/20 0.36
TSHR P16473 1/20 0.36
MAPK1 P28482 1/20 0.36
KDM4E B2RXH2 4/20 0.36
CYP1A2 P05177 2/20 0.36
CYP2C19 P33261 2/20 0.36
SMN1; SMN2 Q16637 2/20 0.36
CYP3A4 P08684 1/20 0.36
TRPA1 O75762 1/20 0.35
PTPRC P08575 2/20 0.34
MYC P01106 1/20 0.33
CA1 P00915 1/20 0.33
CA2 P00918 1/20 0.33
CA7 P43166 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23914735 0.80 KDM4E (0.40) ALDH1A1MAPTKMT2ANPC1HPGD
SCHEMBL23966828 0.79 ALDH1A1 (0.40) ALDH1A1MAPTKMT2ANPC1HPGD
SCHEMBL25310592 0.69 ALDH1A1 (0.59) ALDH1A1KMT2AHPGDMEN1TSHR
SCHEMBL2556108 0.65 MTNR1A (0.42) ALDH1A1KMT2AKDM4ESMN1; SMN2
SCHEMBL23909086 0.63 ALDH1A1 (0.47) ALDH1A1MAPTKMT2AHPGDMEN1
SCHEMBL16410354 0.63 MTNR1A (0.39) ALDH1A1KMT2AHPGDKDM4ESMN1; SMN2
SCHEMBL23909087 0.63 ALDH1A1 (0.47) ALDH1A1MAPTKMT2AHPGDMEN1
SCHEMBL23915344 0.63 ALDH1A1 (0.47) ALDH1A1MAPTKMT2AHPGDMEN1
SCHEMBL18954763 0.63 ALDH1A1 (0.71) ALDH1A1MAPTKMT2AHPGDMEN1
SCHEMBL166198 0.63 ALOX15 (0.52) ALDH1A1KMT2ANPC1HPGDRAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3649119-B1 NOVEL COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS THEREOF FOR THE TREATMENT OF FIBROSIS GALAPAGOS NV (BE) 2021-11-03 EP disclosed